光声成像诊断乳腺良恶性肿块的枢轴性研究:放射科医生的新评估工具
这项前瞻性16中心研究纳入2105名女性,比较激光光声成像联合灰阶超声(OA/US)与单独灰阶超声鉴别乳腺良恶性肿块的诊断效能。结果显示OA/US将良性肿块判读降级40.8%,特异度43.0% vs 28.1%(提高14.9%,P<.0001),但敏感度96.0% vs 98.6%较低(P<.0001)。结论认为OA/US较设备内置灰阶超声提高了乳腺肿块评估的特异度。
要点
- OA/US较设备内置灰阶超声将良性肿块特异度从28.1%提高至43.0%(提高14.9%,P<.0001)。
- OA/US将40.8%(3078/7535)的良性肿块判读降级,有助于减少不必要的活检。
- OA/US对活检恶性肿块敏感度96.0%,低于单独超声的98.6%(P<.0001)。
核心结论
- OA/US较设备内置灰阶超声单独评估提高了乳腺肿块评估的特异度。
研究设计与样本
- 前瞻性16中心研究,2012年12月21日至2015年9月9日纳入2105名女性共2191个肿块,最终分析1690名受试者1757个肿块(良性1079个[61.4%],恶性678个[38.6%]),由7名设盲独立阅片者比较OA/US与单独超声的BI-RADS分类。
诊断标准与关键数值
- OA/US特异度43.0%(3242/7538,99%CI:40.4%,45.7%)vs 设备内置超声28.1%(2120/7543,99%CI:25.8%,30.5%),OA/US特异度高出14.9%(P<.0001;99%CI:12.9,16.9)。
临床应用与阅片要点
- OA/US阴性检查的阴性似然比为0.094,可将超声所赋最高17.8%(低BI-RADS 4B)的验前概率降至2%(BI-RADS 3)的验后概率。
局限性
- 100名受试者(103个肿块)作为训练人群单独分析并排除。
- 202名受试者(210个肿块)因技术失败或成像不完整被排除.
- 72名受试者(78个肿块)因方案偏离被排除。
- 41名受试者(43个肿块)因高风险组织学结果被排除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To compare the diagnostic utility of an investigational optoacoustic imaging device that fuses laser optical imaging (OA) with grayscale ultrasonography (US) to grayscale US alone in differentiating benign and malignant breast masses. Materials and Methods This prospective, 16-site study of 2105 women (study period: 12/21/2012 to 9/9/2015) compared Breast Imaging Reporting and Data System (BI-RADS) categories assigned by seven blinded independent readers to benign and malignant breast masses using OA/US versus US alone. BI-RADS 3, 4, or 5 masses assessed at diagnostic US with biopsy-proven histologic findings and BI-RADS 3 masses stable at 12 months were eligible. Independent readers reviewed US images obtained with the OA/US device, assigned a probability of malignancy (POM) and BI-RADS category, and locked results. The same independent readers then reviewed OA/US images, scored OA features, and assigned OA/US POM and a BI-RADS category. Specificity and sensitivity were calculated for US and OA/US. Benign and malignant mass upgrade and downgrade rates, positive and negative predictive values, and positive and negative likelihood ratios were compared. Results Of 2105 consented subjects with 2191 masses, 100 subjects (103 masses) were analyzed separately as a training population and excluded. An additional 202 subjects (210 masses) were excluded due to technical failures or incomplete imaging, 72 subjects (78 masses) due to protocol deviations, and 41 subjects (43 masses) due to high-risk histologic results. Of 1690 subjects with 1757 masses (1079 [61.4%] benign and 678 [38.6%] malignant masses), OA/US downgraded 40.8% (3078/7535) of benign mass reads, with a specificity of 43.0% (3242/7538, 99% confidence interval [CI]: 40.4%, 45.7%) for OA/US versus 28.1% (2120/7543, 99% CI: 25.8%, 30.5%) for the internal US of the OA/US device. OA/US exceeded US in specificity by 14.9% (P < .0001; 99% CI: 12.9, 16.9%). Sensitivity for biopsied malignant masses was 96.0% (4553/4745, 99% CI: 94.5%, 97.0%) for OA/US and 98.6% (4680/4746, 99% CI: 97.8%, 99.1%) for US (P < .0001). The negative likelihood ratio of 0.094 for OA/US indicates a negative examination can reduce a maximum US-assigned pretest probability of 17.8% (low BI-RADS 4B) to a posttest probability of 2% (BI-RADS 3). Conclusion OA/US increases the specificity of breast mass assessment compared with the device internal grayscale US alone. Online supplemental material is available for this article. © RSNA, 2017.
引用
- Neuschler EI, Butler R, Young CA, et al. A Pivotal Study of Optoacoustic Imaging to Diagnose Benign and Malignant Breast Masses: A New Evaluation Tool for Radiologists. Radiology. 2017. PMID: 29178816. doi:10.1148/radiol.2017172228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。